Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 8.

Journal Article

Ataseven, B., Tripon, D., Schwameis, R., Harter, P., Rhiem, K., Schneider, S., Heikaus, S., Baert, T., Alesina, P., Heitz, F., Traut, A., Groeben, H. T., Schmutzler, R. and du Bois, A. (2021). Impact of BRCA1/2 Germline Status on intraperitoneal Tumor Distribution, Operability, and Incidence of postoperative Complications in Patients with epithelial Ovarian Cancer. Geburtshilfe Frauenheilkd., 81 (4). S. E2 - 2. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804

Belau, A., du Bois, A., Sehouli, J., Reuss, A., Lampe, B., Meier, W., Stuth, R., Forner, D. M., Elling, D., Denschlag, D., Pfisterer, J., Gnauert, K., Armin, B., von Koch, F. E., Valter, M., Mahner, S., Runnebaum, I. B., Schmalfeldt, B., Wagner, U. and Harter, P. (2018). lion-lymphadenectomy in ovarian neoplasms.a prospective randomized ago study group led gynecologyc cancer intergroup trial. Oncol. Res. Treat., 41. S. 13 - 14. BASEL: KARGER. ISSN 2296-5262

Imterat, M., du Bois, A., Harter, P., Rhiem, K., Heitz, F., Concin, N., Traut, A., Schmutzler, R. and Ataseven, B. (2022). Incidence and prognostic impact of pathogenic germline mutations in gene panel testing of primary advanced epithelial ovarian cancer patients. Geburtshilfe Frauenheilkd., 82 (10). S. E97 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804

Liedtke, C., Gluz, O., Heitz, F., Freudenberger, M., Wuestlein, R., Hungermann, D., Ortmann, M., Kates, R. E., Nitz, U., du Bois, A., Fehm, T. N. and Harbeck, N. (2010). Persistent Triple-Negative Phenotype Is Associated with Poorest Outcome among Patients with Metastatic Breast Cancer (BC) - Results of the Retrospective Multicenter PriMet Study Comparing Molecular BC Phenotypes in Primary Tumors and Corresponding Recurrences. Cancer Res., 70. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

Rhiem, K., Wesselmann, S., Mensah, J., Bick, U., Blohmer, J. -U., du Bois, A., Emons, G., Gaissmaier, W., Hahne, A., Koch, K., Meindl, A., Scharl, A. J., Brigitte, S. and Schmutzler, R. K. (2018). Education Program of the German Consortium for Hereditary Breast and Ovarian Cancer and the German Cancer Sociey to improve genetic literacy and trans-sectoral cooperation in the Genome era. Oncol. Res. Treat., 41. S. 183 - 184. BASEL: KARGER. ISSN 2296-5262

Richters, L., Schouten, P. C., Park-Simon, T-W., Hauke, J., Hanker, L., Dietrich, D., Pfisterer, J., Krockenberger, M., Kluin, R., Schnelzer, A., du Bois, A., Kommoss, S., Heimbach, A., Schmidt, S., Marme, F., Prieske, K., Linn, S. C., Schmutzler, R. K., Harter, P. and Hahnen, E. (2018). BRCA-like classification in ovarian cancer - Results from the AGO-TR1-trial. Oncol. Res. Treat., 41. S. 85 - 86. BASEL: KARGER. ISSN 2296-5262

Sehouli, J., Mahner, S., Neunhoeffer, T., Harter, P., de Gregorio, N., Fridrich, C., Markmann, S., Richter, R., Potenberg, J., Lorenz, R., Schmidt, M., Doering, G., Belau, A., Lueck, H. J., Chekerov, R., du Bois, A. and Hilpert, F. (2016). Topotecan (T) +/- Sorafenib (S) for platinum-resistant ovarian cancer (PROC): results of doubleblind placebo-controlled randomized NOGGO - AGO intergroup trial. Int. J. Gynecol. Cancer, 26. S. 2 - 4. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1525-1438

Untch, M., Fasching, P. A., Konecny, G. E., Hasmueller, S., Lebeau, A., Kreienberg, R., Camara, O., Mueller, V., du Bois, A., Kuehn, T., Stickeler, E., Harbeck, N., Hoess, C., Kahlert, S., Beck, T., Fett, W., Mehta, K., von Minckwitz, G. and Loibl, S. (2010). Pathological Complete Response after Neoadjuvant Chemotherapy plus Trastuzumab Treatment Predicts Survival and Detects a Patient Subgroup at High Need for Improvement of Anti-HER2 Therapy. Three Year Median Follow-Up Data of the TECHNO Trial. Cancer Res., 70. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

This list was generated on Fri Mar 29 13:03:31 2024 CET.